The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray Resource
Abstract
The need to better understand the molecular underpinnings of the heterogeneous outcomes of patients with prostate cancer is a pressing global problem and a key research priority for Movember. To address this, the Movember Global Action Plan 1 Unique tissue microarray (GAP1-UTMA) project constructed a set of unique and richly annotated tissue microarrays (TMA) from prostate cancer samples obtained from multiple institutions across several global locations.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Feb 07, 2022
- Source ID
- 10.1158/1055-9965.epi-21-0600
Entities
People
- Adeboye O Osunkoya
- Andrew Erickson
- Angelo M De Marzo
- Anne-Marie Mes-Masson
- Ariel H. Achtman
- Aud Svindland
- Beatrice S Knudsen
- Bruce J Trock
- Carlos S Moreno
- Colm Morrissey
- Dominique Trudel
- Fred Saad
- George S. Bova
- Igor Damasceno Vidal
- Isla P Garraway
- Kathy Wiley
- Kristin Austlid Taskén
- Lawrence D. True
- Mark Buzza
- Michael Lewis
- Michelle M. Kouspou
- On Behalf Of Gap1 Utmas Contributing Investigators
- Onur Ertunç
- Pekka Taimen
- Stephen J. Freedland
- Steven A. Bigler
- Tarja Lamminen
- Tracy Jones
- Tuomas Mirtti
- Viktor Berge
- Véronique Ouellet
- Xinchun Zhou
Organizations
- Cedars-Sinai Medical Center
- Durham VA Medical Center
- Emory University
- Emory University School of Medicine
- Johns Hopkins University
- National Cancer Institute
- Oslo University Hospital
- Tampere University
- Turku University Hospital
- United States Department of Defense
- University of California, Los Angeles
- University of Helsinki
- University of Mississippi
- University of Oslo
- University of Oxford
- University of Turku
- University of Utah
- University of Washington
- Université de Montréal
- Veterans Health Administration